Symbol Lookup from Yahoo Finance

Trending Tickers

Symbol	Name	Last Price	Change	Change %
INTC	Intel Corporation	21.49	+1.82	+9.25%
TSLA	Tesla, Inc.	426.50	+12.68	+3.06%
NVO	Novo Nordisk A/S	78.69	-4.38	-5.27%
TD.TO	TORONTO-DOMINION BANK	83.13	+3.53	+4.43%
BTC-USD	Bitcoin USD	104,620.43	+5,067.92	+5.09%
MSTR	MicroStrategy Incorporated	396.50	+29.50	+8.04%
LLY	Eli Lilly and Company	725.72	-31.88	-4.21%
MRNA	Moderna, Inc.	34.06	+0.30	+0.89%
BTCT	BTC Digital Ltd.	8.26	+3.50	+73.53%
MARA	MARA Holdings, Inc.	19.91	+1.61	+8.80%
JD	JD.com, Inc.	39.00	+3.58	+10.11%
WBA	Walgreens Boots Alliance, Inc.	12.52	-0.41	-3.17%
QRVO	Qorvo, Inc.	84.21	+10.62	+14.43%
^DJI	Dow Jones Industrial Average	43,487.83	+334.70	+0.78%
CRKN	Crown Electrokinetics Corp.	0.1250	+0.0453	+56.84%
^GSPC	S&P 500	5,996.66	+59.32	+1.00%
ETH-USD	Ethereum USD	3,480.14	+198.43	+6.05%
GSIT	GSI Technology, Inc.	3.9500	+1.2000	+43.64%
MRVL	Marvell Technology, Inc.	124.76	+7.18	+6.11%
SLB	Schlumberger N.V.	43.58	+2.49	+6.06%
IBIT	iShares Bitcoin Trust ETF	59.62	+2.53	+4.43%
DOGE-USD	Dogecoin USD	0.41	+0.04	+10.04%
MRK	Merck & Company, Inc.	97.92	-2.78	-2.76%
DOGZ	Dogness (International) Corpora	18.10	-26.12	-59.07%
FNMA	Fannie Mae	6.94	+1.54	+28.52%

Related News

DOJ sues Walgreens for 'unlawful' prescription practices

The US Department of Justice (DOJ) has filed a lawsuit against Walgreens (WBA), one of the nation's largest pharmacy chains, alleging widespread prescription drug practice violations. According to the DOJ, Walgreens improperly dispensed millions of prescriptions from August 2012 to the present day that either lacked "legitimate medical purpose" or were otherwise invalid. Yahoo Finance anchors Josh Lipton and Alexandra Canal dive into the details, discussing the fines the pharmacy giant would face if found liable — up to $80,850 per unlawful prescription. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Angel Smith

Yahoo Finance Video 33 minutes ago

WBA
Nasdaq soars, Dow up 3.7% on the week ahead of Trump inauguration

The US market averages (^DJI, ^IXIC, ^GSPC) are seeing nothing but green as they close out Friday's session with the Nasdaq Composite rising by over 1.5%. The Dow Jones Industrial Average soared by nearly 3.7% over the past five trading days. The session has capped off the best trading week for the S&P 500 and Nasdaq since the 2024 election. Market Domination Overtime's Alexandra Canal and Yahoo Finance markets and data editor Jared Blikre recap the market and sector action in the lasting trading day under the Biden administration, as President-elect Donald Trump preps to reenter the White House this Monday. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 1 hour ago

^NDX

^GSPC
Stocks could be 'protected' from steep declines by Trump: BofA

Bank of America investment strategist Michael Hartnett argued that further downside in the stock market could be protected by Trump's pro-market policies.

Yahoo Finance 5 hours ago

^DJI

^GSPC
Intel stock pops on report of supposed mystery buyer

Intel (INTC) shares are on the rise after SemiAccurate reported that a mystery company is trying to acquire the company as a whole. Alexandra Canal and Josh Lipton break down the report and why it's sending Intel shares higher on Market Domination. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Naomi Buchanan.

Yahoo Finance Video 5 hours ago

INTC
Trump's expected crypto regulation clarity sends bitcoin soaring

Bitcoin (BTC-USD) is yet again trading above the $100,000 mark amid reports that crypto is an early priority for the incoming Trump administration. Delta Blockchain Fund founder and general partner Kavita Gupta joins Catalysts with Seana Smith to discuss the crypto industry heading into Trump's return to the White House. Gupta says the crypto community is relieved that Trump is prioritizing crypto regulation. "There is a big feeling of, 'Thank God we are no more in a gray area,'" she says. "It feels like now, every institution, every government, every country's president is talking about it, which is absolutely great." "We do want to protect retail customers. We want to work within the government bounds ... the clarity on the regulations is and should be the first priority," Gupta adds. Watch the video above to learn about Gupta's expectations for Trump's administration to bolster the US's global standing within the crypto space, crypto initial public offering (IPO) opportunities, and downside risks to bitcoin's rise. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. The post was written by Naomi Buchanan.

Yahoo Finance Video 3 hours ago

BTC-USD
How Trump can deliver on big promises made to the crypto industry

Trump made a lot of promises to crypto enthusiasts in 2024 as he pledged to make the United States the "crypto capital of the planet." Can he deliver on all of them in 2025?

Yahoo Finance 6 hours ago

BTC-USD

COIN
Novo Nordisk's Ozempic & Wegovy in 2027 Medicare price talks

Novo Nordisk's (NVO) GLP-1 weight loss drugs, Ozempic and Wegovy, will be targeted in the next round of Medicare price negotiations in 2027, along with 13 other medications. Seana Smith and Brad Smith break down the details on Morning Brief. The last round of the Inflation Reduction Act (IRA) negotiations gave Medicare an average 22% price reduction for the drugs on this list. With $41 billion in annual Medicare spending on these drugs, the implications for healthcare costs — especially obesity treatments — are massive. However, questions loom around regulatory decisions under a new Trump administration, adding complexity to future outcomes. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Josh Lynch

Yahoo Finance Video 7 hours ago

NONOF

NVO
What Trump is planning for day one — and what could matter most for investors

Donald Trump and his allies are promising a "blizzard" of activity on Jan. 20, with perhaps 100 executive actions to be signed within hours of Trump's swearing-in.

Yahoo Finance 8 hours ago

^DJI
How Musk can deliver on his big ambitions: Fmr. Tesla insider

The venture capital industry has no shortage of ideas right now in the AI space. Companies specializing in everything from mobility to software to chip design are trying to cash in on the AI boom, and VCs are aiming to be there to grow entrepreneurs and drive returns for their investors. Yahoo Finance Yahoo Finance Executive Editor Brian Sozzi chats with one of the more fascinating people in the VC industry Jon McNeill of DVx Ventures. For one, while McNeill is putting to work in AI upstarts, he also has toes in the public company world by sitting on the boards of General Motors (GM) and Lululemon (LULU). What’s more, he has spent the past decade trying to change how people get from point A to point B. He is the former COO of Lyft (LYFT) and also worked very closely with Tesla (TSLA) CEO Elon Musk as president in charge of revenue. What did McNeill learn from the billionaire Musk? How will the future of mobility shake out? And what AI upstarts have caught McNeill's attention? This episode of Opening Bid has a little bit of everything! For full episodes of Opening Bid, listen on your favorite podcast platform or watch on our website.

Yahoo Finance Video 9 hours ago

GM

LULU
Think of 2025 in 2 acts with different strategies for each half

Richard Bernstein Advisors CEO Rich Bernstein tells Julie Hyman and Josh Lipton on Market Domination that investors can think of the market in 2025 as a play with two acts. The strategist describes the economic landscape, saying, "We've got an existing healthy economy, we've got tariffs, we've got all this that it's likely that the [Federal Reserve] will go on hold [and] I think we should we should assume with some possibility as the year goes on, that maybe they have to start raising rates." When looking at how investors should position their portfolios, Bernstein says to think of the year as two acts rather than two halves, noting the "act one portfolio is going to look very different than an act two portfolio." "Act one, I think the economy is stronger than people think [which] argues for a cyclical tilt to a portfolio." He highlights that he's overweight on the energy (XLE) and industrial (XLI) sectors, as well as small and mid-cap equities. The second act of 2025 is uncertain because "if the Fed has to reverse course, act two becomes a more defensive portfolio," with the "textbook" plays being consumer staples, healthcare, and utilities. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Naomi Buchanan.

Yahoo Finance Video 11 hours ago

^GSPC
Moderna Gets $590 Million from US to Study Bird Flu Vaccine

(Bloomberg) -- Moderna Inc. was awarded an additional $590 million from the US government to help the company develop a vaccine aimed at protecting people from bird flu.Most Read from BloombergThese Homes Withstood the LA Fires. Architects Explain WhyNYC Commuters Get New Way to Dodge Traffic: $95 Helicopter RidesScaramucci, Ackman Donate to Whitney Tilson’s NYC Mayoral RunIn a City of Sprawl, Wildfire Evacuation Is Getting HarderWill Americans Ever Lose Their Taste for Telework?The funding will

Bloomberg 37 minutes ago

MRNA
I Still Can’t Get My Head Around Tesla Stock’s (TSLA) Valuation

Tesla (TSLA) stock jumped again on Wednesday, leading the market upwards following some positive inflation data. However, this only served to make the electric vehicle (EV) maker more expensive, with the stock now trading at 160x forward earnings. Despite being broadly supportive of Elon Musk’s business endeavors, I’m bearish on Tesla simply because the valuation is incredibly hard to justify and Musk’s plans hard to quantify. Tesla’s Plans Remain Ambitious I’m bearish on Tesla, but not because

TipRanks 38 minutes ago

TSLA
Equity Markets Rise as Investors Parse Macro Data, IMF Report

US benchmark equity indexes closed higher Friday as traders assessed the latest macro data and the I

PREMIUM
MT Newswires 52 minutes ago

^GSPC

COMP
U.S. Sues Walgreens For Role in Opiod Crisis

The pharmacy and retail chain since August 2012 filled prescriptions that lacked a legitimate medical purpose, were invalid or weren’t issued in professional practice, the DOJ said.

The Wall Street Journal 57 minutes ago

WBA
These Stocks Moved the Most Today: Apple, Alphabet, Qorvo, Novo Nordisk, SLB, J.B. Hunt, Rivian, and More

Apple stock rises after falling Thursday by the most since August, Alphabet stock is up after the Supreme Court upholds a ban on TikTok, and Qorvo stock jumps after activist Starboard Value amasses a large stake in the chip maker.

Barrons.com 1 hour ago

RIVN

AAPL
Moderna Gets $590 Million of Federal Funding For Influenza Vaccines

The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the company said

The Wall Street Journal 1 hour ago

MRNA
Moderna Is Getting $590 Million From the U.S. to Accelerate a Bird Flu Vaccine

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Barrons.com 1 hour ago

MRNA
S&P 500 Has Its Best Week Since November Election: Markets Wrap

(Bloomberg) -- Stocks powered ahead to notch their best week since the November presidential election just ahead of Donald Trump’s inauguration.Most Read from BloombergThese Homes Withstood the LA Fires. Architects Explain WhyNYC Commuters Get New Way to Dodge Traffic: $95 Helicopter RidesScaramucci, Ackman Donate to Whitney Tilson’s NYC Mayoral RunIn a City of Sprawl, Wildfire Evacuation Is Getting HarderWill Americans Ever Lose Their Taste for Telework?Most groups in the S&P 500 rose, with the

Bloomberg 1 hour ago

^GSPC
Tesla Stock 'Valuation Is Full': Analyst Flags Long-Term Growth Opportunities With Robotaxis, FSD

A Tesla Inc (NASDAQ:TSLA) analyst highlighted the monetization opportunities for the company with its robotaxis and FSD. The Tesla Analyst: Goldman Sachs analyst Mark Delaney maintained a Neutral rating on Tesla with a $345 price target. The Analyst ...

Benzinga 1 hour ago

TSLA
Moderna Announces Updates on Pandemic Influenza Program

CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...

ACCESS Newswire 1 hour ago

MRNA

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Trending Tickers

Related News

DOJ sues Walgreens for 'unlawful' prescription practices

Nasdaq soars, Dow up 3.7% on the week ahead of Trump inauguration

Stocks could be 'protected' from steep declines by Trump: BofA

Intel stock pops on report of supposed mystery buyer

Trump's expected crypto regulation clarity sends bitcoin soaring

How Trump can deliver on big promises made to the crypto industry

Novo Nordisk's Ozempic & Wegovy in 2027 Medicare price talks

What Trump is planning for day one — and what could matter most for investors

How Musk can deliver on his big ambitions: Fmr. Tesla insider

Think of 2025 in 2 acts with different strategies for each half

Moderna Gets $590 Million from US to Study Bird Flu Vaccine

I Still Can’t Get My Head Around Tesla Stock’s (TSLA) Valuation

Equity Markets Rise as Investors Parse Macro Data, IMF Report

U.S. Sues Walgreens For Role in Opiod Crisis

These Stocks Moved the Most Today: Apple, Alphabet, Qorvo, Novo Nordisk, SLB, J.B. Hunt, Rivian, and More

Moderna Gets $590 Million of Federal Funding For Influenza Vaccines

Moderna Is Getting $590 Million From the U.S. to Accelerate a Bird Flu Vaccine

S&P 500 Has Its Best Week Since November Election: Markets Wrap

Tesla Stock 'Valuation Is Full': Analyst Flags Long-Term Growth Opportunities With Robotaxis, FSD

Moderna Announces Updates on Pandemic Influenza Program